| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | Dunlop A. Sinclair62 | Director | Sell | 25,000 | $54.67 | $1,366,713.26 | -4.4% | |
| Dec 14, 2020 | Watson David O.70 | General Counsel | Sale+OE | 18,333 | $50.94 | $933,947.48 | -5.5% | |
| Dec 7, 2020 | Dunlop A. Sinclair62 | Director | Sell | 25,000 | $50.59 | $1,264,853.82 | -2.9% | |
| Dec 4, 2020 | Perry Nicole D69 | Vice President - Accounting | Sale+OE | 18,000 | $50.00 | $900,000.00 | -100% | |
| Dec 1, 2020 | Grossi Federico53 | Chief Medical Officer | Sell | 600 | $48.25 | $28,950.00 | -1.8% | |
| Nov 16, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $39.38 | $98,450.00 | -0.4% | |
| Nov 16, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $39.38 | $196,900.00 | -0.5% | |
| Nov 2, 2020 | Grossi Federico53 | Chief Medical Officer | Sell | 600 | $31.09 | $18,654.00 | -2.1% | |
| Oct 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $35.00 | $87,500.00 | -0.4% | |
| Oct 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $34.46 | $172,300.00 | -0.5% |